Literature DB >> 19263246

Chronic administration of androgens with actions at estrogen receptor beta have anti-anxiety and cognitive-enhancing effects in male rats.

Danielle M Osborne1, Kassandra Edinger, Cheryl A Frye.   

Abstract

Androgen levels decline with aging. Some androgens may exert anti-anxiety and cognitive-enhancing effects; however, determining which androgens have anxiolytic-like and/or mnemonic effects is of interest given the different mechanisms that may underlie some of their effects. For example, the 5 alpha-reduced metabolite of testosterone (T), dihydrotesterone, can be further converted to 5 alpha-androstane,17beta-diol-3 alpha-diol (3 alpha-diol) and 5 alpha-androstane,17beta-diol-3beta-diol (3beta-diol), both of which bind with high affinity to the beta isomer of the intracellular estrogen receptor beta (ER beta). However, androsterone, another metabolite of T, does not bind well to ER beta. To investigate the effects of T metabolites, male rats were subjected to gonadectomy then implanted with silastic capsules of 3 alpha-diol, 3beta-diol, androsterone, or oil control. After recovery, the rats were tested in elevated plus maze (EPM), light/dark transition (LD), and Morris water maze (MWM). 3 alpha-diol both decreased anxiety-like behavior in the EPM and LD, and increased cognition in MWM, while 3beta-diol improved cognition in MWM, but had no effects on anxiety behavior, compared to vehicle or androsterone. These data suggest that the actions of 3 alpha-diol and 3beta-diol at ER beta may be responsible for some of testosterone's anti-anxiety and cognitive-enhancing effects.

Entities:  

Year:  2009        PMID: 19263246      PMCID: PMC2693730          DOI: 10.1007/s11357-009-9088-1

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  54 in total

1.  Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats.

Authors:  Kassandra L Edinger; Cheryl A Frye
Journal:  Horm Behav       Date:  2006-04-24       Impact factor: 3.587

2.  Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities.

Authors:  G M Alexander; R S Swerdloff; C Wang; T Davidson; V McDonald; B Steiner; M Hines
Journal:  Horm Behav       Date:  1998-04       Impact factor: 3.587

3.  Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus.

Authors:  Kassandra L Edinger; Cheryl A Frye
Journal:  Behav Neurosci       Date:  2004-12       Impact factor: 1.912

4.  Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus.

Authors:  Kassandra L Edinger; Cheryl A Frye
Journal:  Psychoneuroendocrinology       Date:  2005-01-25       Impact factor: 4.905

5.  Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.

Authors:  Leonard S Marks; Norman A Mazer; Elahe Mostaghel; David L Hess; Frederick J Dorey; Jonathan I Epstein; Robert W Veltri; Danil V Makarov; Alan W Partin; David G Bostwick; Maria Luz Macairan; Peter S Nelson
Journal:  JAMA       Date:  2006-11-15       Impact factor: 56.272

Review 6.  The role of androgens in cognition and brain aging in men.

Authors:  J S Janowsky
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

Review 7.  Benefits of a new testosterone gel formulation for hypogonadal men.

Authors:  Jed C Kaminetsky
Journal:  Clin Cornerstone       Date:  2005

8.  Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test.

Authors:  Alicia A Walf; Madeline E Rhodes; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2004-07       Impact factor: 3.533

9.  Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy.

Authors:  C A Frye; T A Reed
Journal:  Psychoneuroendocrinology       Date:  1998-05       Impact factor: 4.905

10.  Characterization of the cytosol androgen receptor of the human prostate.

Authors:  D M Wilbert; J E Griffin; J D Wilson
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

View more
  1 in total

1.  Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

Authors:  Sonia George; Géraldine H Petit; Gunnar K Gouras; Patrik Brundin; Roger Olsson
Journal:  ACS Chem Neurosci       Date:  2013-09-25       Impact factor: 4.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.